Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202598) titled 'Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Condition:
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis
Intervention:
Drug: Emapalumab
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 15, 2025
Target Sample Size: 10
Countries of Recruitment:
United States
To know more, visit ht...